Literature DB >> 22736230

Fatal hepatic sinusoidal obstruction syndrome in a child with primary CNS lymphoma during induction therapy.

Shohei Yamamoto, Kousuke Akiyama, Nobuo Oyama, Mayumi Hayashi, Yoko Fujimoto, Hirokazu Ikeda, Keiichi Isoyama.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22736230     DOI： 10.1007/s12185-012-1128-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

1.  Veno-occlusive disease of the liver in children treated for Wilms tumor.

Authors:  G Bisogno; J de Kraker; A Weirich; L Masiero; R Ludwig; M F Tournade; M Carli
Journal:  Med Pediatr Oncol       Date:  1997-10

2.  Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Authors:  Oussama Abla; Sheila Weitzman; Jean-Yves Blay; Brian Patrick O'Neill; Lauren E Abrey; Edward Neuwelt; Nancy D Doolittle; Joachim Baehring; Kamnesh Pradhan; S Eric Martin; Michael Guerrera; Shafqat Shah; Hervé Ghesquieres; Michael Silver; Rebecca A Betensky; Tracy Batchelor
Journal:  Clin Cancer Res       Date:  2011-01-11       Impact factor: 12.531

3.  Veno-occlusive disease of the liver in a child after chemotherapy for brain tumor.

Authors:  Murat Elli; Faruk Güçlü Pinarli; Ayhan Dagdemir; Sabri Acar
Journal:  Pediatr Blood Cancer       Date:  2006-04       Impact factor: 3.167

4.  Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.

Authors:  Janina Salzburg; Birgit Burkhardt; Martin Zimmermann; Olga Wachowski; Wilhelm Woessmann; Ilske Oschlies; Wolfram Klapper; Hans-Heinrich Wacker; Wolf-Dieter Ludwig; Felix Niggli; Georg Mann; Helmut Gadner; Hansjoerg Riehm; Martin Schrappe; Alfred Reiter
Journal:  J Clin Oncol       Date:  2007-09-01       Impact factor: 44.544

5.  Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.

Authors:  K M Sullivan; E Kansu; B Storer; J Jocom; G Emerson; T Reagan; V Emerson; M F Siadak; C Davis; F R Appelbaum; C D Buckner; J A Hansen; H M Shulman; R Storb; G B McDonald
Journal:  Biol Blood Marrow Transplant       Date:  1998       Impact factor: 5.742

6.  Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma.

Authors:  M Kashif Ishaqi; A Jamil; M Khanani; M Baroudi; Omar Trad; M El-Hayek; Eric Bouffet
Journal:  J Neurooncol       Date:  2009-08-23       Impact factor: 4.130

7.  Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.

Authors:  G B McDonald; P Sharma; D E Matthews; H M Shulman; E D Thomas
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

8.  Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy.

Authors:  D M Kraemer; J Waschke; V Kunzmann; M Wilhelm
Journal:  Ann Hematol       Date:  2003-05-22       Impact factor: 3.673

9.  Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.

Authors:  Athanasios Papadopoulos; George Ntaios; Georgia Kaiafa; Fotios Girtovitis; Zoi Saouli; Zisis Kontoninas; Michael D Diamantidis; Christos Savopoulos; Apostolos Hatzitolios
Journal:  Int J Hematol       Date:  2008-10-07       Impact factor: 2.490

10.  Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.

Authors:  Y Shibamoto; K Tsutsui; Y Dodo; H Yamabe; N Shima; M Abe
Journal:  Cancer       Date:  1990-05-01       Impact factor: 6.860
  10 in total
  1 in total

Review 1.  Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature.

Authors:  Rishi S Kotecha; Amy Buckland; Marianne B Phillips; Catherine H Cole; Nicholas G Gottardo
Journal:  J Pediatr Hematol Oncol       Date:  2014-01       Impact factor: 1.289
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.